Advertisement

Building a global culture of trial registration

  • Karmela Krleža-Jerić

Keywords

Trial Registration Clinical Trial Registration Medical Journal Editor Global Culture Federal Drug Administration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Office of the New York State Attorney General Eliot Spitzer. Major pharmaceutical firm concealed information. Available at http://www.oag.state.ny.us/press/2004/jun/jun2b_04.html (Accessed 17 March 2005)Google Scholar
  2. 2.
    Krleža-Jerić K (2005) Clinical trial registration: the differing views of industry, the WHO, and the Ottawa Group. PLoS Med 2: e378.PubMedCrossRefGoogle Scholar
  3. 3.
    Goodyear M (2006) Learning from the TGN 1412 trial. Br Med J 332: 677–678CrossRefGoogle Scholar
  4. 4.
    Abbasi K (2004) Compulsory registration of clinical trials. Br Med J 329: 637–638CrossRefGoogle Scholar
  5. 5.
    DeAngelis CD, Drazen JM, Frizelle FA et al (2004) Clinical trial registration: a statement from the International Committee on Medical Journal Editors. JAMA 292: 1363–1364PubMedCrossRefGoogle Scholar
  6. 6.
    Krleža-Jerić K, Chan AW, Dickersin K, Sim I, Grimshaw J, Gluud C (2005) Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). Br Med J 330: 956–958CrossRefGoogle Scholar
  7. 7.
    Dong BJ, Young R, Rapaport B (1986) The nonequivalence of thyroid products. Drug Intell Clin Pharmacol 20: 77–78Google Scholar
  8. 8.
    Eckert CH (1997) Bioequivalence of levothyroxine preparations: industry sponsorship and academic freedom. JAMA 277: 1200–1201PubMedCrossRefGoogle Scholar
  9. 9.
    Rennie D (1997) Thyroid storm. JAMA 277: 1238–1243PubMedCrossRefGoogle Scholar
  10. 10.
    Spigelman MK (1997) Bioequivalence of levothyroxine preparations for treatment of hypothyroidism. JAMA 277: 1199–1200PubMedCrossRefGoogle Scholar
  11. 11.
    Hippocratic Oath. Available at http://www.hal-pc.org/~ollie/hippocratic.oath.html (Accessed 16 April 2006)Google Scholar
  12. 12.
    Declaration of Geneva. http://www.donoharm.org.uk/gendecl.html (Accessed 17 April 2006)Google Scholar
  13. 13.
    Declaration of Helsinki. Ethical principles for medical research involving human subjects. Available at http://www.wma.net/e/policy/pdf.17c.pdf (Accessed 31 March 2006)Google Scholar
  14. 14.
    CIHR Web site. Available at http://www.cihr-irsc.gc.ca (Accessed 31 March 2006)Google Scholar
  15. 15.
    Chan A-W, Krleža-Jerić K, Schmid I, Altman DG (2004) Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ 171: 735–740PubMedGoogle Scholar
  16. 16.
    Chan A-W, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG (2004) Empirical evidence for selective reporting of outcomes in clinical trials. JAMA 291: 2457–2365PubMedCrossRefGoogle Scholar
  17. 17.
    Moher D, Bernstein A (2004) Registering CIHR-funded randomized controlled trials: a global public good. CMAJ 171: 750–775PubMedGoogle Scholar
  18. 18.
    International Standard Randomised Clinical Trial Number. Available at http://isrctn.org (Accessed 15 April 2006)Google Scholar
  19. 19.
    Derbis J, Toigo T, Woods J, Evelyn B, Banks D (2003) FDAMA 113:Information program on clinical trials for serious or life threatening diseases: update on implementation. Ninth Annual FDA Science Forum; April 24, 2003, Washington, DC. Available at http://www.fda.gov/oashi/clinicaltrials/section113/biolaw.html (Accessed 30 March 2006)Google Scholar
  20. 20.
    Toigo T (2004) Food and Drug Modernization Act (FDAMA) Section 113: Status report on implementation. J Biolaw Bus 7. From: http://www.fda.gov (Accessed April 2006)Google Scholar
  21. 21.
    Fergusson D, Glass KC, Hutton B, Shapiro S (2005) Randomized controlled trials of aprotinin in cardiac surgery: Could clinical equipoise have stopped the bleeding? Clin Trials 2: 218–229PubMedCrossRefGoogle Scholar
  22. 22.
    Ottawa Group Web site. Available at http://ottawagroup.ohri.ca (Accessed 1 April 2006)Google Scholar
  23. 23.
    Krleža-Jerić K, Chan AW, Dickersin K, Sim I, Grimshaw J, Gluud C (2005) The Ottawa Statement, Part One: Principles for international registration of protocol information and results from human trials of health-related interventions. Jpn Pharmacol Ther 33: 544–548Google Scholar
  24. 24.
    Evans T, Gülmezoglu M, Pang T (2004) Registering clinical trials: an essential role for WHO. Lancet 363: 1413–1414PubMedCrossRefGoogle Scholar
  25. 25.
    Gülmezoglu AM, Pang T, Horton R, Dickersin K (2005) WHO facilitates international collaboration in setting standards for clinical registration. Lancet 365: 1829–1831PubMedCrossRefGoogle Scholar
  26. 26.
    World Health Organisation Web site. Available at http://www.who.int (Accessed 31 March 2006)Google Scholar
  27. 27.
    Abbasi K, Godlee F (2005) Next steps in trial registration; minimum criteria have been agreed, and intentions restated. Br Med J 330: 1222–1223CrossRefGoogle Scholar
  28. 28.
    De Angelis C, Drazen JM, Frizelle FA et al (2005) Is this clinical trial fully registered? — A statement from the International Committee of Medical Journal Editors. N Engl J Med 325: 2436–2438CrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2006

Authors and Affiliations

  • Karmela Krleža-Jerić
    • 1
  1. 1.Randomised Controlled Trials UnitCanadian Institutes of Health ResearchOttawaCanada

Personalised recommendations